Activation of the endocannabinoid system in schizophrenia: A compensatory mechanism of subclinical inflammation?

Schizophr Res. 2023 Feb:252:67-68. doi: 10.1016/j.schres.2022.12.050. Epub 2023 Jan 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Endocannabinoids*
  • Humans
  • Inflammation
  • Receptor, Cannabinoid, CB1
  • Schizophrenia*

Substances

  • Endocannabinoids
  • Receptor, Cannabinoid, CB1